Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Recruiting 3Completed 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3Ovarian Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 51Specimen Handling 42enzalutamide 36Androgen Antagonists 35Radiosurgery 33Radiotherapy 31darolutamide 26Prednisone 26Abiraterone Acetate 25Leuprolide 22Docetaxel 22apalutamide 21abiraterone 19Pluvicto 19Standard of Care 18Triptorelin Pamoate 17Radiation 17Biopsy 16relugolix 15acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 15Goserelin 14Blood Specimen Collection 13gallium 68 PSMA-11 12X-Rays 11Surveys and Questionnaires 11pembrolizumab 10luprolide acetate gel depot 10Carboplatin 10Methods 9Interviews as Topic 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Prostatic Neoplasms × Sugars × Clear all
NCT02064673 2026-03-30

Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy

University of Texas Southwestern Medical Center

Phase 3 Recruiting
650 enrolled
Genitourinary

Prostatic Neoplasms

NCT05726292 2026-03-04

A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer

University of Chicago

Phase 2 Recruiting
90 enrolled
Genitourinary

Prostatic Neoplasms

NCT03769766 2025-06-11

Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance

University of Texas Southwestern Medical Center

Phase 3 Recruiting
291 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡